ABN-202 (αTROP2)

N/A

Report date: 2026/04/15 20:02:38

Base Information

Drug NameABN-202 (αTROP2)

Drug Alias NameABN202 (αTROP2)ABN-202 (αTROP2)

ClassificationBiologics > Protein drugs > Recombinant protein > Fusion proteinBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody

Mechanisms of ActionApoptosis stimulantsAnti-Trop-2Interferon beta inhibitors

TargetsTumor-associated calcium signal transducer 2Interferon beta

Therapy Area/IndicationsHR-positive breast cancerCarcinoma, Non-Small-Cell LungTriple Negative Breast Neoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritorySouth Korea

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesAbion Inc

China Registration ClassN/A

Develop Information

Active CompaniesAbion Inc

Inactive CompaniesN/A

Active IndicationsHR-positive breast cancerCarcinoma, Non-Small-Cell LungTriple Negative Breast Neoplasms

Inactive IndicationsN/A

Other Information

ATC CodeN/A